The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Role of Nitric Oxide in the Cardiovascular and Renal Systems
Open accessAbstract
The gasotransmitters are a family of gaseous signaling molecules which are produced endogenously and act at specific receptors to play imperative roles in physiologic and pathophysiologic processes. As a well-known gasotransmitter along with hydrogen sulfide and carbon monoxide, nitric oxide (NO) has earned repute as a potent vasodilator also known as endothelium-derived vasorelaxant factor (EDRF). NO has been studied in greater detail, from its synthesis and mechanism of action to its physiologic, pathologic, and pharmacologic roles in different disease states. Different animal models have been applied to investigate the beneficial effects of NO as an antihypertensive, renoprotective, and antihypertrophic agent. NO and its interaction with different systems like the renin–angiotensin system, sympathetic nervous system, and other gaseous transmitters like hydrogen sulfide are also well studied. However, links that appear to exist between the endocannabinoid (EC) and NO systems remain to be fully explored. Experimental approaches using modulators of its synthesis including substrate, donors, and inhibitors of the synthesis of NO will be useful for establishing the relationship between the NO and EC systems in the cardiovascular and renal systems. Being a potent vasodilator, NO may be unique among therapeutic options for management of hypertension and resulting renal disease and left ventricular hypertrophy. Inclusion of NO modulators in clinical practice may be useful not only as curatives for particular diseases but also for arresting disease prognoses through its interactions with other systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?
Wang, R. (2002) · The FASEB Journal · doi:10.1096/fj.02-0211hyp · Cited by 1,807
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Hosoki, R., Matsuki, N., & Kimura, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6878 · Cited by 1,218
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
Wallace, J. L., & Wang, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4433 · Cited by 878
Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro, M. O., Antunes, E., de Nucci, G., Lovisolo, S. M., & Zatz, R. (1992) · Hypertension · doi:10.1161/01.hyp.20.3.298 · Cited by 786
Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms
Barouch, L. A., Harrison, R. W., Skaf, M. W., Rosas, G. O., Cappola, T. P., Kobeissi, Z. A., Hobai, I. A., Lemmon, C. A., Burnett, A. L., O'Rourke, B., et al. (2002) · Nature · doi:10.1038/416337a · Cited by 761
Nitric Oxide and Cardiac Function: Ten Years After, and Continuing
Massion, P. B., Feron, O., Dessy, C., & Balligand, J.-L. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 567
Higashi, Y., Sasaki, S., Kurisu, S., Yoshimizu, A., Sasaki, N., Matsuura, H., Kajiyama, G., & Oshima, T. (1999) · Circulation · doi:10.1161/01.cir.100.11.1194 · Cited by 552
NO-independent regulatory site on soluble guanylate cyclase
Stasch, J.-P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Minuth, T., Perzborn, E., Pleiß, U., et al. (2001) · Nature · doi:10.1038/35065611 · Cited by 545
H2S-induced vasorelaxation and underlying cellular and molecular mechanisms
Zhao, W., & Wang, R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00013.2002 · Cited by 505
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459 · cited 1×
“Essential hypertension [138] and LVH [139] are each associated with higher sympathetic activity and elevated NA levels and reduced NO levels, while NO donor treatment reversed these changes in hypertension [140] and LVH [56].”
BackgroundL-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.
Chen, P. Y., & Sanders, P. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115467 · Cited by 450
Takimoto, E., Champion, H. C., Li, M., Ren, S., Rodriguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521968 · Cited by 450
YC-1, a novel activator of platelet guanylate cyclase
Ko, F., Wu, C., Kuo, S., Lee, F., & Teng, C. (1994) · Blood · doi:10.1182/blood.v84.12.4226.bloodjournal84124226 · Cited by 402
Sakuma, I., Togashi, H., Yoshioka, M., Saito, H., Yanagida, M., Tamura, M., Kobayashi, T., Yasuda, H., Gross, S. S., & Levi, R. (1992) · Circulation Research · doi:10.1161/01.res.70.3.607 · Cited by 384
Whiteman, M., Li, L., Kostetski, I., Chu, S. H., Siau, J. L., Bhatia, M., & Moore, P. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.154 · Cited by 377
Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
Ali, M. Y., Ping, C. Y., Mok, Y., Ling, L., Whiteman, M., Bhatia, M., & Moore, P. K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706906 · Cited by 349
Calver, A., Collier, J., Moncada, S., & Vallance, P. J. (1992) · PubMed · Cited by 332
Paolocci, N., Katori, T., Champion, H. C., St. John, M. E., Miranda, K. M., Fukuto, J. M., Wink, D. A., & Kass, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937302100 · Cited by 315
Stasch, J., Schmidt, P., Alonso‐Alija, C., Apeler, H., Dembowsky, K., Haerter, M., Heil, M., Minuth, T., Perzborn, E., Pleiss, U., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704778 · Cited by 313
Defective l -Arginine–Nitric Oxide Pathway in Offspring of Essential Hypertensive Patients
Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Sudano, I., & Salvetti, A. (1996) · Circulation · doi:10.1161/01.cir.94.6.1298 · Cited by 311
Scherrer-Crosbie, M., Ullrich, R., Bloch, K. D., Nakajima, H., Nasseri, B., Aretz, H. T., Lindsey, M. L., Vançon, A.-C., Huang, P. L., Lee, R. T., et al. (2001) · Circulation · doi:10.1161/hc3601.094298 · Cited by 310
Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure
Lahera, V., Salom, M. G., Miranda-Guardiola, F., Moncada, S., & Romero, J. C. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.6.f1033 · Cited by 283
Nitroxyl (HNO): the Cinderella of the nitric oxide story
Irvine, J. C., Ritchie, R. H., Favaloro, J. L., Andrews, K. L., Widdop, R. E., & Kemp-Harper, B. K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.005 · Cited by 277
Inhibition of nitric oxide synthesis increases blood pressure in healthy humans
Haynes, W. G., Noon, J. P., Walker, B. R., & Webb, D. J. (1993) · Journal of Hypertension · doi:10.1097/00004872-199312000-00009 · Cited by 277
Schwarz, P., Diem, R., Dun, N. J., & Förstermann, U. (1995) · Circulation Research · doi:10.1161/01.res.77.4.841 · Cited by 275
An introduction to the endocannabinoid system: from the early to the latest concepts
De Petrocellis, L., & Di Marzo, V. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 251
Shinozaki, K., Nishio, Y., Okamura, T., Yoshida, Y., Maegawa, H., Kojima, H., Masada, M., Toda, N., Kikkawa, R., & Kashiwagi, A. (2000) · Circulation Research · doi:10.1161/01.res.87.7.566 · Cited by 242
Calver, A., Collier, J., Moncada, S., & Vallance, P. (1992) · Journal of Hypertension · doi:10.1097/00004872-199209000-00017 · Cited by 240
Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262789099 · Cited by 239
Modulation of endogenous production of H2S in rat tissues
Zhao, W., Ndisang, J. F., & Wang, R. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-077 · Cited by 224
Downregulation of Angiotensin II Type 1 Receptor Gene Transcription by Nitric Oxide
Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K., & Takeshita, A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.342 · Cited by 211
Mechanism of YC-1-Induced Activation of Soluble Guanylyl Cyclase
Friebe, A., & Koesling, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.123 · Cited by 201
Lake, K. D., Compton, D. R., Varga, K., Martin, B. R., & Kunos, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36714-x · Cited by 201
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
Ozawa, K., Whalen, E. J., Nelson, C. D., Mu, Y., Hess, D. T., Lefkowitz, R. J., & Stamler, J. S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.024 · Cited by 187
Kubo, S., Doe, I., Kurokawa, Y., Nishikawa, H., & Kawabata, A. (2007) · Toxicology · doi:10.1016/j.tox.2006.12.023 · Cited by 183
Hayakawa, H., & Raij, L. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.235 · Cited by 177
Transport of endocannabinoids across the plasma membrane and within the cell
Fowler, C. J. (2013) · The FEBS Journal · doi:10.1111/febs.12212 · Cited by 168
Lake, K. D., Martin, B. R., Kunos, G., & Varga, K. (1997) · Hypertension · doi:10.1161/01.hyp.29.5.1204 · Cited by 159
Reduced Plasma Concentrations of Nitrogen Oxide in Individuals With Essential Hypertension
Node, K., Kitakaze, M., Yoshikawa, H., Kosaka, H., & Hori, M. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.405 · Cited by 156
Recoupling the Cardiac Nitric Oxide Synthases: Tetrahydrobiopterin Synthesis and Recycling
Alkaitis, M. S., & Crabtree, M. J. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0097-5 · Cited by 154
Mechanism of Elevated Plasma Noradrenaline in the Course of Essential Hypertension
Esler, M., Jennings, G., Biviano, B., Lambert, G. W., & Hasking, G. J. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198608005-00008 · Cited by 151
Mechanism of the Hypotensive Action of Anandamide in Anesthetized Rats
Varga, K., Lake, K. D., Huangfu, D., Guyenet, P. G., & Kunos, G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.682 · Cited by 151
Gokce, N. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2807s · Cited by 146
Vacek, T. P., Rahman, S., Yu, S., Neamtu, D., Givvimani, S., & Tyagi, S. C. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s68415 · Cited by 137
Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl
Yong, Q. C., Hu, L.-F., Wang, S., Huang, D., & Bian, J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq248 · Cited by 135
Gokce, N., Holbrook, M., Duffy, S. J., Demissie, S., Cupples, L. A., Biegelsen, E. S., Keaney, J. F., Loscalzo, J., & Vita, J. A. (2001) · Hypertension · doi:10.1161/hy1201.096575 · Cited by 132
Palloshi, A., Fragasso, G., Piatti, P., Monti, L. D., Setola, E., Valsecchi, G., Galluccio, E., Chierchia, S. L., & Margonato, A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.040 · Cited by 130
Sodium Nitroprusside: Mechanism of NO Release Mediated by Sulfhydryl-Containing Molecules
Grossi, L., & D'Angelo, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049857n · Cited by 129
Blood pressure and metabolic changes during dietary L-arginine supplementation in humans
Siani, A., Pagano, E., Iacone, R., Iacoviello, L., Scopacasa, F., & Strazzullo, P. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00233-2 · Cited by 129
Lee, D.-Y., Wauquier, F., Eid, A. A., Roman, L. J., Ghosh-Choudhury, G., Khazim, K., Block, K. L., & Gorin, Y. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470971 · Cited by 126
Ford, W. R., Honan, S. A., White, R., & Hiley, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704565 · Cited by 117
Chronic l -Arginine Administration Attenuates Cardiac Hypertrophy in Spontaneously Hypertensive Rats
Matsuoka, H., Nakata, M., Kohno, K., Koga, Y., Nomura, G., Toshima, H., & Imaizumi, T. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.14 · Cited by 117
Ruetten, H., Dimmeler, S., Gehring, D., Ihling, C. H., & Zeiher, A. M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.021 · Cited by 115
Ichinose, F., Bloch, K. D., Wu, J. C., Hataishi, R., Aretz, H. T., Picard, M. H., & Scherrer‐Crosbie, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00940.2003 · Cited by 114
The role of nitric oxide in hypertension and renal disease progression
Klahr, S. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.60 · Cited by 112
Production and functional roles of nitric oxide in the proximal tubule
Liang, M., & Knox, F. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.5.r1117 · Cited by 112
Rizzoni, D., Muiesan, M. L., Porteri, E., et al. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715020-00011 · Cited by 109
Effects of l -Arginine Infusion on Renal Hemodynamics in Patients With Mild Essential Hypertension
Higashi, Y., Oshima, T., Ozono, R., Watanabe, M., Matsuura, H., & Kajiyama, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.898 · Cited by 104
Crabos, M., Coste, P., Paccalin, M., Tariosse, L., Daret, D., Besse, P., & Bonoron‐Adèle, S. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0251 · Cited by 103
Niederhoffer, N., Schmid, K., & Szabó, B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0755-y · Cited by 100
Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?
Sears, C. E., Ashley, E. A., & Casadei, B. (2004) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2004.1477 · Cited by 97
Nitric-oxide-mediated regulation of cardiac contractility and stretch responses
Casadei, B., & Sears, C. E. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(03)00006-3 · Cited by 92
The Potential Role of Nitric Oxide in the Hypertrophic Growth of the Left Ventricle
Šimko, F., & Šimko, J. (2000) · Physiological Research · doi:10.33549/physiolres.930000.49.37 · Cited by 90
Galougahi, K. K., Liu, C., Gentile, C., Kok, C., Nunez, A., Garcia, A., Fry, N. A. S., Davies, M. J., Hawkins, C. L., Rasmussen, H. H., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000731 · Cited by 89
Ozaki, M., Kawashima, S., Yamashita, T., Hirase, T., Ohashi, Y., Inoue, N., Hirata, K., & Yokoyama, M. (2002) · Circulation Journal · doi:10.1253/circj.66.851 · Cited by 88
β-Arrestins and G Protein-Coupled Receptor Trafficking
Kang, D. S., Tian, X., & Benovic, J. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391862-8.00005-3 · Cited by 87
Kolo, L. L., Westfall, T. C., & Macarthur, H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00668.2003 · Cited by 84
Cellular Distribution and Function of Soluble Guanylyl Cyclase in Rat Kidney and Liver
Theilig, F., Bostanjoglo, M., Pavenstädt, H., Grupp, C., Holland, G., Slosarek, I., Gressner, A. M., Russwurm, M., Koesling, D., & Bachmann, S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112209 · Cited by 84
Ms, C., Chin, P. S., Vemulapalli, S., Watkins, R. W., & Sybertz, E. J. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169160 · Cited by 81
Intravenous administration of L-arginine inhibits angiotensin- converting enzyme in humans
Higashi, Y., Oshima, T., Ono, N., Hiraga, H., Yoshimura, M., Watanabe, M., Matsuura, H., Kambe, M., & Kajiyama, G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608279 · Cited by 81
Stein, E. A., Fuller, S. A., Edgemond, W. S., & Campbell, W. B. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15683.x · Cited by 79
Nitrosothiol formation and S-nitrosation signaling through nitric oxide synthases
Wynia‐Smith, S. L., & Smith, B. C. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.10.001 · Cited by 78
Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat
Chin, S. Y., Wang, C.-T., Majid, D. S. A., & Navar, L. G. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.5.f876 · Cited by 74
Barouch, L. A., Cappola, T. P., Harrison, R. W., Crone, J. K., Rodriguez, E. R., Burnett, A. L., & Hare, J. M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00079-8 · Cited by 73
Buys, E. S., Raher, M. J., Blake, S. L., Neilan, T. G., Graveline, A. R., Passeri, J. J., Llano, M., Pérez-Sanz, T. M., Ichinose, F., Janssens, S. P., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01236.2006 · Cited by 72
A Kinetic Study of S-Nitrosothiol Decomposition
Grossi, L., & Montevecchi, P. C. (2002) · Chemistry - A European Journal · Cited by 70
Dhaese, I., & Lefebvre, R. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.011 · Cited by 67
Zhang, H., Wu, J., Dong, H., Khan, S. A., Chu, M., & Tsuda, T. (2013) · Clinical Science · doi:10.1042/cs20120636 · Cited by 63
Pucci, M. L., Lin, L., & Nasjletti, A. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10967-1 · Cited by 60
The nitric oxide pathway in the cardiovascular system
Llorens, S., Jordán, J., & Nava, E. (2002) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179855 · Cited by 59
MARTIN, S., Emanuel, K., Sears, C. L., Zhang, Y. H., & Casadei, B. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.002 · Cited by 58
Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension
Qiu, C., Engels, K. J., & Baylis, C. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.5.r1470 · Cited by 56
S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence
Hayashi, H., Hess, D. T., Zhang, R., Sugi, K., Gao, H., Tan, B. L., Bowles, D. E., Milano, C. A., Jain, M. K., Koch, W. J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.034 · Cited by 54
Ito, K., Chen, J., Seshan, S. V., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00429.x · Cited by 53
Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla
Ritter, J. K., Li, C., Xia, M., Poklis, J. L., Lichtman, A. H., Abdullah, R. A., Dewey, W. L., & Li, P. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196451 · Cited by 53
Self-citationZanfolin, M., Faro, R., de Araújo, E. G., Guaraldo, A. M. A., Antunes, E., & Nucci, G. D. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000210071.54828.9b · Cited by 53
Role of cGMP in hydrogen sulfide signaling
Bibli, S., Yang, G., Zhou, Z., Wang, R., Topouzis, S., & Papapetropoulos, A. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.12.004 · Cited by 52
Gaucher, C., Boudier, A., Dahboul, F., Parent, M., & Leroy, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143635 · Cited by 51
Jiang, Q., Zhou, Z., Wang, L., Yang, C., Wang, J., Wu, T., & Song, L. (2014) · Scientific Reports · doi:10.1038/srep06963 · Cited by 46
Lepori, M., Sartori, C. S., Trueb, L., Owlya, R., NICOD, P. H., & Scherrer, U. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816040-00013 · Cited by 46
Wu, D., Hu, Q., Ma, F., & Zhu, Y. Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7075682 · Cited by 43
Ahmad, A., Sattar, M. Z. A., Rathore, H. A., Abdulla, M. H., Khan, S. A., Azam, M., Abdullah, N. A., & Johns, E. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150137 · Cited by 43
Self-citationMotteleb, D. M. A. E., & Elshazly, S. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.033 · Cited by 40
Gaucher, C., Boudier, A., Dahboul, F., Parent, M., & Leroy, P. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811306030458 · Cited by 40
Waghe, P., Sarath, T. S., Gupta, P., Kandasamy, K., Choudhury, S., Harikumar, S. K., Mishra, S. K., & Sarkar, S. N. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.06.014 · Cited by 39
Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system
Pfitzer, T., Niederhoffer, N., & Szabó, B. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-1003-9 · Cited by 39
Grandvuillemin, I., Buffat, C., Boubred, F., Lamy, E., Fromonot, J., Charpiot, P., Simoncini, S., Sabatier, F., Dignat‐George, F., Peyter, A., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00354.2017 · Cited by 38
Stefano, G. B., Esch, T., Cadet, P., Zhu, W. M., Mantione, K. J., & Benson, H. (2003) · PubMed · Cited by 36
Sánchez-Mendoza, A., Hong, E., & Escalante, B. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816050-00018 · Cited by 36
Kashihara, T., Nakada, T., Kojima, K., Takeshita, T., & Yamada, M. (2017) · The Journal of Physiology · doi:10.1113/jp273883 · Cited by 36
Hydrogen sulfide induces nitric oxide release from nitrite
Grossi, L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.030 · Cited by 35
Kazakov, A., Müller, P., Jagoda, P., Semenov, A., Böhm, M., & Laufs, U. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr305 · Cited by 35
Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney.
Feng, F., Pettinger, W. A., Abel, P. W., & Jeffries, W. B. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20271-3 · Cited by 32
Tóth, A. D., Gyombolai, P., Szalai, B., Várnai, P., Turu, G., & Hunyady, L. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.027 · Cited by 29
Podjarny, E., Hasdan, G., Bernheim, J., Rashid, G., Green, J., Korzets, Z., & Bernheim, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh383 · Cited by 28
A critical review of pharmacological significance of Hydrogen Sulfide in hypertension
Sattar, M. Z. A., Ahmad, A., Rathore, H. A., Khan, S., Lazhari, M., Afzal, S., Hashmi, F., Abdullah, N., & Johns, E. J. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.157106 · Cited by 27
Self-citationLankadeva, Y. R., Singh, R. R., Moritz, K. M., Parkington, H. C., Denton, K. M., & Tare, M. (2014) · Circulation · doi:10.1161/circulationaha.114.013930 · Cited by 26
Luce, V., Fernández‐Solari, J., Rettori, V., & Laurentiis, A. D. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.12.004 · Cited by 26
Miller, A. L. (2006) · PubMed · Cited by 26
Květňanský, R., Pacák, K., Tokarev, D., Jeloková, J., Ježová, D., & Rusnák, M. (1997) · Neurochemical Research · doi:10.1023/a:1022426910111 · Cited by 25
Singh, R. R., Easton, L. K., Booth, L. C., Schlaich, M. P., Head, G. A., Moritz, K. M., & Denton, K. M. (2016) · Scientific Reports · doi:10.1038/srep26777 · Cited by 25
Ahmad, A., Sattar, M. Z. A., Azam, M., Khan, S. A., Bhatt, O., & Johns, E. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189386 · Cited by 24
Self-citationMikusic, N. L. R., Kouyoumdzian, N. M., Uceda, A., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.04.010 · Cited by 23
Flanagan, E., Buckley, M. M., Aherne, C. M., Lainis, F., Sattar, M. Z. A., & Johns, E. J. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.043216 · Cited by 21
Moustafa, A., & Habara, Y. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5108 · Cited by 21
Ahmad, A., Sattar, M. Z. A., Rathore, H. A., Abdulla, M. H., Khan, S. A., Abdullah, N. A., Kaur, G., & Johns, E. J. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0236 · Cited by 16
Self-citationSchneider, M. K., Xue, B., & Shi, H. (2018) · Physiological Reports · doi:10.14814/phy2.13645 · Cited by 15
Santillo, M. F., & Mapa, M. S. T. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2375 · Cited by 11
Abdulla, M. H., Sattar, M. Z. A., Johns, E. J., et al. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0180-9 · Cited by 9
The Adrenal Gland as a Source of Dihydroxyphenylalanine and Catecholamine Metabolites
Tyce, G. M., Chritton, S. L., Barnes, R. D., et al. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60768-1 · Cited by 6
Cited by
Vascular Endothelial Cell Biology: An Update
Krüger-Genge, A., Blocki, A., Franke, R.-P., & Jung, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184411 · Cited by 1,163
The emerging role of oxidative stress in inflammatory bowel disease
Muro, P., Zhang, L., Li, S., Zhao, Z., Jin, T., Mao, F., & Mao, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390351 · Cited by 279
Kurhaluk, N., & Tkaczenko, H. (2025) · Nutrients · doi:10.3390/nu17040665 · Cited by 62
“Repeated donations have been shown to induce a state of enhanced NO production and vascular responsiveness within the body, thereby facilitating expedited recovery and optimised adaptation to periodic fluctuations in oxygen delivery [4,81].”
InfluentialEbirim, C. G., Esan, O., Adetona, M. O., Oyagbemi, A. A., Omobowale, T. O., Oladele, O. A., Adedapo, A. A., Oguntibeju, O. O., & Yakubu, M. A. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-24656-4 · Cited by 13
Salivary-Gland-Mediated Nitrate Recirculation as a Modulator for Cardiovascular Diseases
Pang, B., Qi, X., & Zhang, H. (2025) · Biomolecules · doi:10.3390/biom15030439 · Cited by 3
Metadata
- Authors
- Ahmad, A., Dempsey, S. K., Daneva, Z., Azam, M., Li, N., Li, P.-L., & Ritter, J. K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-09-03
- Volume
- 19
- Issue
- 9
- Pages
- 2605
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2889488205
- Cited by
- 278
- References
- 128
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.